Growth Metrics

Biofrontera (BFRIW) Return on Capital Employed (2021 - 2025)

Historic Return on Capital Employed for Biofrontera (BFRIW) over the last 5 years, with Q3 2025 value amounting to 3.37%.

  • Biofrontera's Return on Capital Employed fell 12200.0% to 3.37% in Q3 2025 from the same period last year, while for Sep 2025 it was 3.37%, marking a year-over-year decrease of 12200.0%. This contributed to the annual value of 1.32% for FY2024, which is 2600.0% down from last year.
  • As of Q3 2025, Biofrontera's Return on Capital Employed stood at 3.37%, which was down 12200.0% from 12.33% recorded in Q2 2025.
  • Over the past 5 years, Biofrontera's Return on Capital Employed peaked at 12.33% during Q2 2025, and registered a low of 3.37% during Q3 2025.
  • In the last 5 years, Biofrontera's Return on Capital Employed had a median value of 1.31% in 2024 and averaged 0.47%.
  • Over the last 5 years, Biofrontera's Return on Capital Employed had its largest YoY gain of 137100bps in 2025, and its largest YoY loss of -12200bps in 2025.
  • Over the past 5 years, Biofrontera's Return on Capital Employed (Quarter) stood at 1.23% in 2021, then skyrocketed by 53bps to 0.58% in 2022, then tumbled by -203bps to 1.75% in 2023, then decreased by -18bps to 2.08% in 2024, then plummeted by -62bps to 3.37% in 2025.
  • Its last three reported values are 3.37% in Q3 2025, 12.33% for Q2 2025, and 1.94% during Q1 2025.